List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 752 studies with search of: "Rituximab"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Multi-Center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   CLL;   Untreated;   Front-Line;   First-Line;   Initial Therapy
Interventions: Drug: Lenalidomide and Rituximab;   Drug: Lenalidomide and Rituximab
2 Active, not recruiting A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Condition: Refractory Myasthenia Gravis
Intervention: Drug: Rituximab (Rituxan)
3 Recruiting Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
Conditions: Follicular Lymphomas;   Immunocytomas;   Marginal Zone Lymphomas;   Mantle-Cell Lymphomas;   Non-Hodgkin's Lymphoma
Interventions: Drug: Rituximab;   Drug: Rituximab / observation
4 Recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Intervention: Drug: lenalidomide-low dose dexamethasone plus rituximab
5 Recruiting The Effect of Rituximab on the Development of Anti-Donor Antibodies
Condition: Renal Transplant Rejection
Interventions: Drug: Rituximab;   Drug: No Rituximab
6 Recruiting SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: Placebo;   Drug: Methotrexate
7 Recruiting A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: Galiximab in combination with rituximab;   Drug: Rituximab in combination with placebo
8 Active, not recruiting Rituximab+Standard CHOP vs Rituximab+bi-Weekly CHOP for Untreated Stage III/IV Low-Grade B-Cell Lymphoma (JCOG0203)
Condition: Lymphoma, B-Cell
Interventions: Drug: Rituximab + Standard CHOP;   Drug: Rituximab + Bi-weekly CHOP
9 Terminated Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: fludarabine and rituximab;   Drug: fludarabine, rituximab, pixantrone
10 Recruiting Zevalin® First Line in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: 90Yttrium-Ibritumomab Tiuxetan (Zevalin®)+Rituximab;   Drug: Rituximab
11 Not yet recruiting A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-Cell Chronic Lymphocytic Leukemia
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: cladribine;   Drug: cyclophosphamide;   Drug: rituximab [MabThera/Rituxan]
12 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
13 Active, not recruiting A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: Methotrexate
14 Completed R-ICE (ICE Plus Rituximab) Versus R-DHAP (DHAP Plus Rituximab) in Patients Aged 18-65 With Relapse Diffuse Large B-Cell Lymphoma
Condition: Lymphoma, Large-Cell, Diffuse
Interventions: Drug: DHAP plus rituximab;   Drug: ICE plus rituximab
15 Active, not recruiting A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan]
16 Recruiting Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
Conditions: Diffuse Large Cell Lymphoma;   Lymphoma
Interventions: Drug: Zevalin;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Rituximab;   Procedure: Stem Cell Transplant
17 Recruiting Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia
Condition: Advanced Refractory Chronic Lymphocytic Leukemia
Intervention: Drug: Rituximab (Mabthera) , FFP (Fresh Frozen Plasma)
18 Recruiting Effect of B-Cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjögren's Syndrome;   Xerostomia;   Hyposalivation;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
19 Recruiting Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
Condition: Lymphoma, Large-Cell, Diffuse
Interventions: Drug: CHOP+RITUXIMAB;   Drug: CEEP-RITUXIMAB
20 Recruiting Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-Cell Lymphoma, a Form of Non-Hodgkin's Lymphoma
Condition: Lymphoma, Follicular
Interventions: Drug: Rituximab + Sargramostim (Leukine, BAY86-5326);   Drug: Rituximab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services